Ad W. van Gorp
Directeur Général chez Cytura Therapeutics BV
Profil
Ad W.
van Gorp is the founder who has founded two companies.
In 2007, he founded Lead Pharma Holding BV where he held the title of Chief Executive Officer.
In 2019, he founded Cytura Therapeutics BV where he currently holds the title of Chief Executive Officer.
Dr. van Gorp's former jobs include being a Principal at Kiadis BV, Unilever UK Ltd., Janssen Pharmaceutica NV, and Numico Research BV.
Dr. van Gorp's education history includes a doctorate from Maastricht University and a graduate degree from the University of Utrecht, which was conferred in 1993.
Postes actifs de Ad W. van Gorp
| Sociétés | Poste | Début |
|---|---|---|
Cytura Therapeutics BV
 Cytura Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Cytura Therapeutics BV is a Dutch company that focuses on finding a solution to stop destabilization of the genome. The company is based in Oss, Netherlands. The company aims to target genomic instability as a stand-alone therapy or in combination therapy to avoid therapy resistance or relapse, which will help make cancer treatment more effective and improve the lives of patients worldwide. The company was founded by Ad W. van Gorp, who has been the CEO since incorporation. | Directeur Général | 01/01/2019 |
Anciens postes connus de Ad W. van Gorp
| Sociétés | Poste | Fin |
|---|---|---|
| Numico Research BV | Corporate Officer/Principal | - |
Kiadis BV
 Kiadis BV Pharmaceuticals: MajorHealth Technology Kiadis BV is a drug discovery and development company with a focus on oncology and metabolic disorders. Kiadis has developed a proprietary technology platform, BioSelact technology that is used to perform drug discovery screening programs using natural extracts as well as synthetic mixtures and with the key advantage of direct identification and dereplication of the active compounds present in extracts or mixtures. The company is headquartered in Groningen, the Netherlands. | Corporate Officer/Principal | - |
Janssen Pharmaceutica NV
 Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Janssen Pharmaceutica NV engages in the development of medical solutions. It offers research and development services in the field of mental illness, neurological disorders, anesthesia, analgesia, gastrointestinal disorders, fungal infection, allergies and cancer. The firms products include Zytiga, Caelyx, Dacogen, Edurant, Fentanyl-Janssen, Intelence, Leustatin, , Pariet, and Reminyl. The company was founded in 1953 by Paul Janssen and is headquartered in Beerse, Belgium. | Corporate Officer/Principal | - |
Unilever UK Ltd.
 Unilever UK Ltd. Food: Major DiversifiedConsumer Non-Durables Unilever UK Ltd. manufactures, markets and distributes packaged consumer goods. The firm offers products in the areas of foods, home care and personal care. The company is headquartered in Leatherhead, the United Kingdom. | Corporate Officer/Principal | - |
Lead Pharma Holding BV
 Lead Pharma Holding BV Pharmaceuticals: MajorHealth Technology Lead Pharma Holding BV develops small-molecule drugs for the treatment of autoimmune diseases and cancer. It specializes in medicinal, computational, and protein chemistry, x-ray crystallography, cell biology, and integration x-omics. The company was founded by Ad van Gorp, Leon de Windt, and Pieter Doevendans in 2007 and is headquartered in Oss , the Netherlands. | Directeur Général | - |
Formation de Ad W. van Gorp
| Maastricht University | Doctorate Degree |
| University of Utrecht | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Kiadis BV
Kiadis BV Pharmaceuticals: MajorHealth Technology Kiadis BV is a drug discovery and development company with a focus on oncology and metabolic disorders. Kiadis has developed a proprietary technology platform, BioSelact technology that is used to perform drug discovery screening programs using natural extracts as well as synthetic mixtures and with the key advantage of direct identification and dereplication of the active compounds present in extracts or mixtures. The company is headquartered in Groningen, the Netherlands. | Health Technology |
Unilever UK Ltd.
Unilever UK Ltd. Food: Major DiversifiedConsumer Non-Durables Unilever UK Ltd. manufactures, markets and distributes packaged consumer goods. The firm offers products in the areas of foods, home care and personal care. The company is headquartered in Leatherhead, the United Kingdom. | Consumer Non-Durables |
Janssen Pharmaceutica NV
Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Janssen Pharmaceutica NV engages in the development of medical solutions. It offers research and development services in the field of mental illness, neurological disorders, anesthesia, analgesia, gastrointestinal disorders, fungal infection, allergies and cancer. The firms products include Zytiga, Caelyx, Dacogen, Edurant, Fentanyl-Janssen, Intelence, Leustatin, , Pariet, and Reminyl. The company was founded in 1953 by Paul Janssen and is headquartered in Beerse, Belgium. | Health Technology |
| Numico Research BV | |
Cytura Therapeutics BV
Cytura Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Cytura Therapeutics BV is a Dutch company that focuses on finding a solution to stop destabilization of the genome. The company is based in Oss, Netherlands. The company aims to target genomic instability as a stand-alone therapy or in combination therapy to avoid therapy resistance or relapse, which will help make cancer treatment more effective and improve the lives of patients worldwide. The company was founded by Ad W. van Gorp, who has been the CEO since incorporation. | Commercial Services |
Lead Pharma Holding BV
Lead Pharma Holding BV Pharmaceuticals: MajorHealth Technology Lead Pharma Holding BV develops small-molecule drugs for the treatment of autoimmune diseases and cancer. It specializes in medicinal, computational, and protein chemistry, x-ray crystallography, cell biology, and integration x-omics. The company was founded by Ad van Gorp, Leon de Windt, and Pieter Doevendans in 2007 and is headquartered in Oss , the Netherlands. | Health Technology |